Dongdong Luo

机构：Dalian Medical University, Sichuan University, West China Hospital of Sichuan University, Jiaxing University, Second Affiliated Hospital of Dalian Medical University, Center for Molecular Medicine and Immunology, First Hospital of China Medical University, Molecular Oncology (United States), Guangzhou Medical University Cancer Hospital, State Key Laboratory of Biotherapy, Zhejiang University of Technology, China Medical University, Guangzhou Medical University

发表论文 24 篇 · 总被引 244 次 · h-index 7

代表论文

Teaching-learning-based optimization of a composite metastructure in the 0–10 kHz broadband sound absorption range (2020 · The Journal of the Acoustical Society of America · 被引 91)
miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma (2016 · Oncotarget · 被引 38)
Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment (2024 · Journal of Medicinal Chemistry · 被引 23)
Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma (2024 · European Journal of Medicinal Chemistry · 被引 17)
Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p (2022 · Journal of Neuro-Oncology · 被引 15)
The establishment of lipid profiles reference ranges during pregnancy: a systematic review and meta-analysis (2025 · Reproductive Biology and Endocrinology · 被引 7)